Pyrazinamide may possess cardioprotective properties.

Sinha, Sharabh; Du, Qingyou; Jovanovic, Sofija; Sukhodub, Andriy; Jovanovic, Aleksandar

Sinha, Sharabh; Du, Qingyou; Jovanovic, Sofija; Sukhodub, Andriy; Jovanovic, Aleksandar.

Afiliação

Sinha S; Division of Molecular and Clinical Medicine, Medical School, University of Dundee, Nethergate, Dundee, DD1 4HN, UK.
Du Q; Division of Molecular and Clinical Medicine, Medical School, University of Dundee, Nethergate, Dundee, DD1 4HN, UK.
Jovanovic S; Division of Molecular and Clinical Medicine, Medical School, University of Dundee, Nethergate, Dundee, DD1 4HN, UK.
Sukhodub A; Division of Molecular and Clinical Medicine, Medical School, University of Dundee, Nethergate, Dundee, DD1 4HN, UK.
Jovanovic A; University of Nicosia Medical School, Egkomi, Cyprus. jovanovic.a@unic.ac.cy.

J Antibiot (Tokyo) ; 72(9): 714-717, 2019 09.

Article em En | MEDLINE | ID: mdl-31243346

Assuntos

Antituberculosos/farmacologia; Cardiotônicos/farmacologia; Pirazinamida/farmacologia; Animais; Linhagem Celular; Canais KATP; Ratos; Estresse Fisiológico/efeitos dos fármacos; Receptores de Sulfonilureias/metabolismo

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirazinamida / Cardiotônicos / Antituberculosos Limite: Animals Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google